GSKs Combination Meningitis Vaccine Receives FDA Approval

by Kathy Jones on  June 15, 2012 at 10:43 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

GlaxoSmithKline has announced that its combination meningitis vaccine, MenHibrix has been approved by the US Food and Drug Administration as a protective vaccination for infants against two bacterial diseases.
 GSKs Combination Meningitis Vaccine Receives FDA Approval
GSKs Combination Meningitis Vaccine Receives FDA Approval

MenHibrix is a combination of GSK's meningococcal and Hib vaccines and is administered in a four-dose series at 2, 4, 6 and 12 through 15 months of age. The company said that the vaccine will prevent diseases caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.

Commenting on the approval, GSK Vaccines vice president Leonard Friedland said, "MenHibrix gives healthcare providers the option of combining Hib immunization with meningococcal C and Y immunization without increasing the number of shots for infants and toddlers."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Japanese Encephalitis Hib Vaccine Meningitis Vaccination for Children Top 10 Vaccine Myths Debunked Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive